advertisement

Topcon

Kuwayama Y 1

Showing records 1 to 1 | Display all abstracts from Kuwayama Y

53948 Phase 1 Clinical Trials of a Selective Rho Kinase Inhibitor, K-115
Tanihara H; Inoue T; Yamamoto T; Kuwayama Y; Abe H; Araie M;
JAMA ophthalmology 2013; 0: 1-8

Issue 15-2

Change Issue


advertisement

Oculus